Adults aged 18-80 years with a formal diagnosis of MS.
Participants must be ambulatory and report problems with walking and/or balance.
Have stable disease with no relapses in the last 3 months.
Agreement to not introduce or change the dosage of pharmaceutical treatments during the study period. This includes intramuscular injections (e.g., Botox), intravenous, and orally administered drugs.
Agreement to maintain the frequency, duration and intensity of physical therapy or any alternate therapies (e.g., massage, osteopathic, chiropractic, etc.) for the duration of the trial.
You may not be if
Unable to follow instructions due to cognitive deficit or language barrier
Presence of visual disorders that prevent meaningful interaction with the intervention interface.
Unable to maintain stable pharmaceutical treatment for the duration of the study.
Unable to maintain the frequency, duration and intensity of physical therapy or alternate therapies outside of the trial for the duration of the trial.
Received Botox treatment within 3 months of the onset of the study.
